JRSIS HEALTH CARE CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
JRSIS HEALTH CARE CORPORATION (JRSS) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$1.53 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-20.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-12-20
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$2.83K, a 151.44% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $5.51K, a 95.53% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-03-31 was $123.29K.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2021-03-31 was -$11.93K.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$7.94K.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$8.00K, a 110.44% decline from fiscal 2021.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was $76.59K.
- JRSIS HEALTH CARE CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2020 was -$67.50K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -$1.53K 10-Q · filed 2024-12-20 | |||||||
| 2024-06-30 | -$5.09K 10-Q · filed 2024-09-05 | |||||||
| 2024-03-31 | -$2.83K 10-Q · filed 2024-05-29 | |||||||
| 2023-12-31 | -$7.94K 10-K · filed 2024-04-26 | |||||||
| 2023-09-30 | -$2.55K 10-Q · filed 2024-12-20 | -$5.05K 10-Q · filed 2023-11-15 | ||||||
| 2023-06-30 | -$19.87K 10-Q · filed 2024-09-05 | -$2.02K 10-Q · filed 2023-08-21 | ||||||
| 2023-03-31 | $5.51K 10-Q · filed 2024-05-29 | -$3.33K 10-Q · filed 2023-05-22 | ||||||
| 2022-12-31 | -$8.00K 10-K · filed 2024-04-26 | -$298.07K 10-K · filed 2023-04-17 | ||||||
| 2022-09-30 | -$276.56K 10-Q · filed 2023-11-15 | |||||||
| 2022-06-30 | -$284.56K 10-Q · filed 2023-08-21 | |||||||
| 2022-03-31 | $123.29K 10-Q · filed 2023-05-22 | |||||||
| 2021-12-31 | $76.59K 10-K/A · filed 2023-08-31 | |||||||
| 2021-09-30 | $8.77K 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | -$49.88K 10-Q · filed 2022-09-15 | |||||||
| 2021-03-31 | -$11.93K 10-Q · filed 2022-05-20 | |||||||
| 2020-12-31 | -$67.50K 10-K · filed 2022-04-15 |